Resumo
La histoplasmosis diseminada es una micosis oportunista producida por el hongo Histoplasma capsulatum, con manifestaciones clínicas variadas y con una relación con el Virus de la Inmunodeficiencia Humana. Los pacientes con reciente inicio de terapia antirretroviral tienen mayor riesgo de agravamiento de infecciones oportunistas subyacentes o reactivación de infecciones enmascaradas secundario al desarrollo del Síndrome Inflamatorio de Reconstitución Inmune. El objetivo de este artículo es presentar el caso de un paciente de 25 años con antecedente de VIH con reciente inicio de terapia antirretroviral, quien presenta síntomas constitucionales, compromiso respiratorio y lesiones cutáneas generalizadas, con aislamiento en muestra de lavado alveolar y biopsia cutánea de estructuras micóticas compatibles con histoplasma; configurando así un caso de histoplasmosis diseminada en contexto del Síndrome Inflamatorio de Reconstitución Inmune, con manifestaciones cutáneas inusuales. Se resalta la importancia de identificar esta entidad poco frecuente y sus manifestaciones, las cuales pueden resultar atípicas y severas.
Referências
Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany- Moretlwe S, Taiwo B, et al. HIV infection. Nat Rev Dis Primers. 2023;9(1):42.
Myint T, Anderson AM, Sanchez A, Farabi A, Hage C, Baddley JW, et al. Histoplasmosis in patients with human immunodeficiency virus/ acquired immunodeficiency syndrome (HIV/ AIDS): multicenter study of outcomes and factors associated with relapse. Medicine (Baltimore). 2014;93(1):11-18.
Batista JM, Martins MAP, Bertollo CM. Primary cutaneous histoplasmosis difficult to treat in immunocompetent patient: case report and literature review. Einstein (Sao Paulo). 2021;19:eRC5488.
Araúz AB, Papineni P. Histoplasmosis. Infect Dis Clin North Am. 2021;35(2):471-491.
Couppié P, Herceg K, Bourne-Watrin M, Thomas V, Blanchet D, Alsibai KD, et al. The Broad Clinical Spectrum of Disseminated Histoplasmosis in HIV-Infected Patients: A 30 Years’ Experience in French Guiana. J fungi (Basel, Switzerland). 2019;5(4):115.
Hidrón A, González Á. Síndrome inflamatorio de reconstitución inmune en pacientes infectados con el virus de la inmunodeficiencia humana y afecciones fúngicas. Infectio. 2012;16(3S):51-58.
Rodriguez-Hernandez A, Zavala-Trujillo IG, Arceo-Ramos M, Guzman-Rivera Z, Zavala-Cerna MG. Síndrome Inflamatorio de Reconstitución Inmune (SIRI), avances en su fisiopatogenia y consideraciones generales para el tratamiento. Open J Med. 2016;5(2):20-34.
Sharma, Surendra K, Soneja M. HIV & inmune reconstitution inflamatory syndrome (IRIS). Indian J Med Res. 2011;134(6):866-877.
Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Incidence and Lethality of Immune Reconstitution Disease in HIV-Infected Patients Starting Antiretroviral Therapy: Systematic Review and Meta-Analysis. Lancet Infect Dis. 2010;10(4):251-261.
Beishuizen SJ, Geerlings SE. Inmune reconstitution inflammatory syndrome: inmunopathogenesis, risk factors, diagnosis, treatment and prevention. Neth J Med. 2009;67(10):327-331.
French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS. 2004;18(12):1615-1627.
Robertson J, Meier M, Wall J, Ying J, Fichtenbaum CJ. Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. Clin Infect Dis. 2006;42(11):1639-1646.
Gopal R, Rapaka RR, Kolls JK. Immune reconstitution inflammatory syndrome associated with pulmonary pathogens. Eur Respir Rev. 2017;26:160042:1-8.
Peigne V, Dromer F, Elie C, Lidove O, Lortholary O,French Mycosis Study Group. Imported acquired immunodeficiency syndromerelated histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active antiretroviral therapy eras. Am J Trop Med Hyg. 2011;85(5):934-941.
Melzani A, de Reynal de Saint Michel R, Ntab B, Djossou F, Epelboin L, Nacher M, et al. Incidence and Trends in Immune Reconstitution Inflammatory Syndrome Associated With Histoplasma capsulatum Among People Living With Human Immunodeficiency Virus: A 20-Year Case Series and Literature Review.Clin Infect Dis. 2020;70(4):643-652.
Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore). 2007;86(3):162-169.
Cunha VS, Zampese MS, Aquino VR, Cestari TF, Goldani LZ. Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population. Clin Exp Dermatol. 2007;32(3):250-255.
Ollague Sierra JE, Ollague Torres JM. New clinical and histological patterns of acute disseminated histoplasmosis in human immunodeficiency virus-positive patients with acquired immunodeficiency syndrome. Am J Dermatopathol. 2013;35(2):205-212.
K Ramdial P, Mosam A, Dlova NC, B Satar N, Aboobaker J, Singh SM. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol. 2002;29(4):215-225.
Astigarraga I, González-Granado LI, Allende LM, Alsina L. Síndromes hemofagocíticos: la importancia del diagnóstico y tratamiento precoces. An Pediatr (Barc). 2018;89:124.e1-8.
Reyes-Corcho A, Bouza-Jiménez Y. Síndrome de reconstitución inmunológica asociado al virus de la inmunodeficiencia humana y sida. Estado del arte. Enferm Infecc Microbiol Clin. 2010;28(2):110-121.
Dhasmana DJ, Dheda K, Ravn P, Wilkinson RJ, Meintjes G. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs. 2008;68(2):191-208.
Tobón AM, Agudelo CA, Rosero DS, Ochoa JE, De Bedout C, Zuluaga A, et al. Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. Am J Trop Med Hyg. 2005;73(3):576-582.
Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med. 2002;137(2):105-109.
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Revista Médicas UIS